JASKO STEVEN,PAL AJAI,ZEITLIN ANDY,ZHANG XIAOKUI,KANG LIN,HEIDARAN MOHAMMAD A,HARIRI ROBERT J
申请号：
ZA201106982
公开号：
ZA201106982B
申请日:
2011.09.23
申请国别(地区):
ZA
年份:
2016
代理人:
摘要：
Provided herein are placenta-derived intermediate natural killer cells for use in methods of suppressing tumor cell proliferation, or treating individuals having cancer or a viral infection. The method comprises contacting the tumor cells, or administering to the individual, placental perfusate, placental perfusate cells, or natural killer cells, e.g., placenta-derived intermediate natural killer cells. The method may further comprises administering an immunomodulatory compound or thalidomide.
